Phase 3 Relapsed Ovarian Cancer Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Active
Phase 3
A randomised, placebo-controlled, trial of concurrent cediranib [AZD2171] (with platinum-based chemotherapy) and concurrent and maintenance cediranib in women with platinum-sensitive relapsed ovarian cancer.
Platinum sensitive relapsed ovarian cancer
AstraZenica500 enrolled1 locationACTRN12610000160033
Recruiting
Phase 3
A Phase 3 study comparing the combination of CAELYX and YONDELIS (the study drug) with CAELYX alone in subjects with advanced relapsed ovarian cancer who have previously had platinum based chemotherapy treatment (eg. Carboplatin/Cisplatin)
Advanced relapsed Ovarian Cancer - to prolong progression free survival
Johnson & Johnson Pharmaceutical Research & Development650 enrolled1 locationACTRN12607000169448